TGA approves new form of weightloss medicine Wegovy pill, with daily pill set to be available before Christmas

Australians will soon be able to swap weight-loss injections for a pill, with a new form of popular medicine Wegovy approved by the Therapeutic Goods Administration.

Headshot of Taylor Renouf
Taylor Renouf
The West Australian
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) Credit: UCG/UCG/Universal Images Group via G

Australians will soon be able to swap weight-loss injections for a pill, with a new form of popular medicine Wegovy approved by the Therapeutic Goods Administration.

A once-daily pill will be available to Australians before Christmas, according to 7NEWS, with more than 10,000 residents already signed up to the waiting list.

Wegovy manufacturer Novo Norsdisk said the company was “working to bring the new treatment option”, with other GLP-1 medications such as Wegovy, Ozempic and Mounjaro only available in Australia as injections.

Sign up to The Nightly's newsletters.

Get the first look at the digital newspaper, curated daily stories and breaking headlines delivered to your inbox.

Email Us
By continuing you agree to our Terms and Privacy Policy.

The new pill will be able to be swallowed every morning on an empty stomach.

A Department of Health spokesman said the Wegovy pill will be available in 1.5mg, 4mg, 9mg and 25mg strengths.

“The indications are consistent with those approved for the injectable formulation of Wegovy,” a spokesman said.

The approval comes just more than three months after Australia’s medicine regulator issued a safety warning over the popular weight-loss drugs, saying they could cause a rare vision disorder.

The TGA said those medicines have the potential to cause a rare, but severe, form of eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION).

The disorder may result in permanent visual impairment, including blindness. There is currently no treatment for it.

The TGA urges any patients who experience sudden vision loss, even if only partial, should seek urgent medical attention.

Originally published on The West Australian

Comments

Latest Edition

The Nightly cover for 03-11-2026

Latest Edition

Edition Edition 3 November 20263 November 2026

Homeowners cop it again in fight against inflation, but Treasurer says he’s not to blame.